1. Home
  2. PCVX
  3. PCVX News

Latest Vaxcyte Inc. (PCVX) News on February 22, 2025

It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care
PCVX

Investor's Business Daily

8 days ago

It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
PCVX

GlobeNewswire

9 days ago

Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
PCVX

Investor's Business Daily

10 days ago

RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.

Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts
PCVX

Insider Monkey

14 days ago

Why Vaxcyte, Inc. (PCVX) Is Among the Best Healthcare Stocks To Buy According to Analysts

PCVX

MT Newswires

14 days ago

Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31
PCVX

TipRanks

16 days ago

Vaxcyte advances second stage of Phase 2 study evaluating VAX-31

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants
PCVX

Clinical Trials Arena

16 days ago

Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants

PCVX

MT Newswires

17 days ago

Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
PCVX

GlobeNewswire

17 days ago

Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
PCVX

Zacks

19 days ago

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
PCVX

GlobeNewswire

22 days ago

Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference

Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts?
PCVX

Insider Monkey

a month ago

Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts?

PCVX

MT Newswires

a month ago

Vaxcyte Insider Sold Shares Worth $427,923, According to a Recent SEC Filing

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III
PCVX

Zacks

2 months ago

Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?
PCVX

Insider Monkey

2 months ago

Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?

PCVX

MT Newswires

2 months ago

Vaxcyte Insider Sold Shares Worth $710,249, According to a Recent SEC Filing

What Makes Vaxcyte (PCVX) An Investment Bet?
PCVX

Insider Monkey

2 months ago

What Makes Vaxcyte (PCVX) An Investment Bet?

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants
PCVX

Clinical Trials Arena

3 months ago

Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
PCVX

GlobeNewswire

3 months ago

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug
PCVX

Insider Monkey

3 months ago

Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug

PCVX

MT Newswires

3 months ago

Vaxcyte Insider Sold Shares Worth $686,518, According to a Recent SEC Filing

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
PCVX

GlobeNewswire

3 months ago

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
PCVX

Simply Wall St.

3 months ago

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight
PCVX

GuruFocus.com

4 months ago

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update
PCVX

GlobeNewswire

4 months ago

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

Should You Consider Investing in Vaxcyte (PCVX)?
PCVX

Insider Monkey

4 months ago

Should You Consider Investing in Vaxcyte (PCVX)?

PCVX

MT Newswires

4 months ago

Vaxcyte Insider Sold Shares Worth $4,846,508, According to a Recent SEC Filing

PCVX

MT Newswires

5 months ago

Vaxcyte Insider Sold Shares Worth $6,283,861, According to a Recent SEC Filing

PCVX

MT Newswires

5 months ago

Vaxcyte Insider Sold Shares Worth $927,551, According to SEC Filing

PCVX

MT Newswires

5 months ago

Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing

Vaxcyte, Inc. (PCVX): Among Hedge Funds’ Top Biotech Stock Picks
PCVX

Insider Monkey

5 months ago

Vaxcyte, Inc. (PCVX): Among Hedge Funds’ Top Biotech Stock Picks

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference
PCVX

GlobeNewswire

5 months ago

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference

PCVX

MT Newswires

5 months ago

Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating

PCVX

MT Newswires

5 months ago

Vaxcyte Closes $1.5 Billion Offering of Shares, Warrants

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
PCVX

GlobeNewswire

6 months ago

Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise
PCVX

BioPharma Dive

6 months ago

Obesity drug startup raises $67M; Vor’s ‘shielded transplant’ shows promise

PCVX

MT Newswires

6 months ago

Vaxcyte Prices $1.3 Billion Offering of Shares, Warrants

Vaxcyte Announces Pricing of $1.3 Billion Public Offering
PCVX

GlobeNewswire

6 months ago

Vaxcyte Announces Pricing of $1.3 Billion Public Offering

Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results
PCVX

Zacks

6 months ago

Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results

Company News for Sep 4, 2024
PCVX

Zacks

6 months ago

Company News for Sep 4, 2024

Vaccine Maker Raising $1 Billion Leads Post-Holiday Share Sales
PCVX

Bloomberg

6 months ago

Vaccine Maker Raising $1 Billion Leads Post-Holiday Share Sales

PCVX

MT Newswires

6 months ago

Vaxcyte Starts $1 Billion Underwritten Public Offering

Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market
PCVX

Investor's Business Daily

6 months ago

Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
PCVX

GlobeNewswire

6 months ago

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

PCVX

MT Newswires

6 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

PCVX

MT Newswires

6 months ago

Sector Update: Health Care Stocks Retreat in Afternoon Trading

PCVX

MT Newswires

6 months ago

Sector Update: Health Care

Heard on the Street: Pfizer Better Watch Out for This Biotech
PCVX

The Wall Street Journal

6 months ago

Heard on the Street: Pfizer Better Watch Out for This Biotech

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
PCVX

Benzinga

6 months ago

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher

Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market
PCVX

Investor's Business Daily

6 months ago

Vaxcyte Catapults 34% As It Looks To Take On Pfizer In A $10 Billion Market

PCVX

MT Newswires

6 months ago

Sector Update: Health Care

PCVX

MT Newswires

6 months ago

Vaxcyte Plans Phase 3 Trial for 31-Valent Pneumococcal Conjugate Vaccine Candidate After 'Positive' Phase 1/2 Study Results

Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
PCVX

GlobeNewswire

6 months ago

Vaxcyte Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
PCVX

GlobeNewswire

6 months ago

Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

PCVX

MT Newswires

6 months ago

Vaxcyte Insider Sold Shares Worth $1,184,767, According to a Recent SEC Filing

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update
PCVX

GlobeNewswire

7 months ago

Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)
PCVX

GuruFocus.com

7 months ago

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)

Wall Street Analysts See a 25.16% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?
PCVX

Zacks

7 months ago

Wall Street Analysts See a 25.16% Upside in Vaxcyte (PCVX): Can the Stock Really Move This High?

Are You Looking for a Top Momentum Pick? Why Vaxcyte, Inc. (PCVX) is a Great Choice
PCVX

Zacks

7 months ago

Are You Looking for a Top Momentum Pick? Why Vaxcyte, Inc. (PCVX) is a Great Choice

PCVX

MT Newswires

7 months ago

Vaxcyte Insider Sold Shares Worth $1,263,912, According to a Recent SEC Filing

PCVX

MT Newswires

7 months ago

Vaxcyte Insider Sold Shares Worth $649,325, According to a Recent SEC Filing

PCVX

MT Newswires

7 months ago

Vaxcyte Insider Sold Shares Worth $425,000, According to a Recent SEC Filing

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)
PCVX

GuruFocus.com

8 months ago

Insider Sale: COO Jim Wassil Sells 3,000 Shares of Vaxcyte Inc (PCVX)

Vaxcyte Appoints John Furey to Board of Directors
PCVX

GlobeNewswire

8 months ago

Vaxcyte Appoints John Furey to Board of Directors

PCVX

MT Newswires

9 months ago

Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely
PCVX

Simply Wall St.

9 months ago

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely

PCVX

GuruFocus.com

9 months ago

Vaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational Overview

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
PCVX

GlobeNewswire

9 months ago

Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update

Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares
PCVX

GuruFocus.com

10 months ago

Insider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 Shares

PCVX

MT Newswires

10 months ago

Vaxcyte Insider Sold Shares Worth $490,199, According to a Recent SEC Filing

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
PCVX

GlobeNewswire

a year ago

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference

Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
PCVX

GuruFocus.com

a year ago

Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances

Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares
PCVX

GuruFocus.com

a year ago

Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares

30 Biggest Biotechnology Companies in the World
PCVX

Insider Monkey

a year ago

30 Biggest Biotechnology Companies in the World

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
PCVX

GlobeNewswire

a year ago

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants

PCVX

Thomson Reuters StreetEvents

a year ago

Q4 2023 Vaxcyte Inc Earnings Call

Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know
PCVX

Zacks

a year ago

Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript
PCVX

Insider Monkey

a year ago

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript
PCVX

Insider Monkey

a year ago

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PCVX

GlobeNewswire

a year ago

Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
PCVX

Zacks

a year ago

The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte

Why Vaxcyte (PCVX) Might Surprise This Earnings Season
PCVX

Zacks

a year ago

Why Vaxcyte (PCVX) Might Surprise This Earnings Season

5 Stocks to Buy That Are Poised to Beat on Earnings This Week
PCVX

Zacks

a year ago

5 Stocks to Buy That Are Poised to Beat on Earnings This Week

Insider Sell: Vaxcyte Inc CFO Andrew Guggenhime Disposes of 8,000 Shares
PCVX

GuruFocus.com

a year ago

Insider Sell: Vaxcyte Inc CFO Andrew Guggenhime Disposes of 8,000 Shares

Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
PCVX

GlobeNewswire

a year ago

Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Director Heath Lukatch Sells 5,000 Shares of Vaxcyte Inc (PCVX)
PCVX

GuruFocus.com

a year ago

Director Heath Lukatch Sells 5,000 Shares of Vaxcyte Inc (PCVX)

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
PCVX

GlobeNewswire

a year ago

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Director Heath Lukatch Sells 4,000 Shares of Vaxcyte Inc (PCVX)
PCVX

GuruFocus.com

a year ago

Director Heath Lukatch Sells 4,000 Shares of Vaxcyte Inc (PCVX)

Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
PCVX

GlobeNewswire

a year ago

Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference

Regional bank that played rescuer in 2023 now in turmoil
PCVX

Yahoo Finance

a year ago

Regional bank that played rescuer in 2023 now in turmoil

U.S. Steel (X) to Report Q4 Earnings: What's in the Cards?
PCVX

Zacks

a year ago

U.S. Steel (X) to Report Q4 Earnings: What's in the Cards?

SQ vs. SOFI: Which Fintech Stock Is the Better Buy?
PCVX

TipRanks

a year ago

SQ vs. SOFI: Which Fintech Stock Is the Better Buy?

Vaxcyte Announces Pricing of $750 Million Public Offering
PCVX

GlobeNewswire

a year ago

Vaxcyte Announces Pricing of $750 Million Public Offering

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
PCVX

GlobeNewswire

a year ago

Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

Qualys' (QLYS) VMDR to Enhance Orange Cyberdefense's Solution
PCVX

Zacks

a year ago

Qualys' (QLYS) VMDR to Enhance Orange Cyberdefense's Solution

Shockwave Medical names Renee Gaeta CFO
PCVX

MedTech Dive

a year ago

Shockwave Medical names Renee Gaeta CFO

Biden vows action after US soldiers killed by drone strike
PCVX

Yahoo Finance Video

a year ago

Biden vows action after US soldiers killed by drone strike

PCVX

GlobeNewswire

a year ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
PCVX

GlobeNewswire

a year ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older
PCVX

GlobeNewswire

a year ago

Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older

Share on Social Networks: